Lantheus Holdings, Inc. Public Market Comparables
Find the most relevant public market comparables for Lantheus Holdings, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company that develops, manufactures, and distributes diagnostic and therapeutic products for oncology, cardiology, and other therapeutic areas. They offer products assisting healthcare professionals in the diagnosis and treatment of various diseases. The company has a history spanning over 65 years and has made several acquisitions expanding their portfolio.
Business Model
Development, manufacturing, and distribution of radiopharmaceutical diagnostic and therapeutic products.
Target Customers
Hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacies, and clinics.
Specific Focus
Precision diagnostic and therapeutic products, with a focus on oncology and cardiology.
Location
Bedford , Massachusetts
CEO
Brian Markison
Industry
Life sciences
Sub Sector
Radiopharmaceuticals
3yr Revenue Growth
282%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Lantheus Holdings, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Lantheus Holdings, Inc.? Our platform provides detailed analysis of Lantheus Holdings, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Lantheus Holdings, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Lantheus Holdings, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals sector, Lantheus Holdings, Inc. operates in the specialized Radiopharmaceuticals sub-sector. Understanding how Lantheus Holdings, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Radiopharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
MannKind Corp
Biopharmaceutical • Life sciences
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. It offers products including inhaled insulin, wearable insulin delivery devices, and treatments for pulmonary arterial hypertension.
Y-mAbs Therapeutics, Inc.
Biotechnology • Life sciences
Y-mAbs Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel, antibody-based therapeutic products for cancer treatment. They utilize technologies such as their investigational Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform and bispecific antibodies generated using the Y-BiClone platform. Their product pipeline includes DANYELZA (naxitamab-gqgk), an FDA-approved treatment for relapsed or refractory neuroblastoma.
Aytu BioPharma, Inc.
Pharmaceuticals • Life sciences
Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on commercializing novel therapeutics. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), and has a commercial portfolio of prescription therapeutics and consumer health products.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Lantheus Holdings, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free